IGF2R Domain 1-7, His & Avi, Human
IGF2R Domain 1-7, His & Avi, Human

The purity of IGF2R Domain 1-7, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

IGF2R Domain 1-7, His & Avi, Human

IGF2R Domain 1-7, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

IGF2R Domain 1-7, His & Avi, Human

The cation-independent mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is a multifunctional receptor. It is involved in a variety of cellular processes which become dysregulated in cancer.
Z05406
¥72,752.00

Ask us a question
Product Introduction
Species Human
Protein Construction
IGF2R Domain 1-7 (Glu47-Pro1079)
Accession # P11717		 His Avi
N-term C-term
Purity > 95% as determined by Bis­Tris PAGE 
> 95% as determined by HPLC
Endotoxin Level Less than 1EU per μg by the LAL method.
Expression System HEK293
Theoretical Molecular Weight 117.40 kDa
Apparent Molecular Weight Due to glycosylation, the protein migrates to 120-160 kDa based on Bis-Tris PAGE result.
Formulation Lyophilized from 0.22μm filtered solution in PBS (pH 7.4).
Reconstitution Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.
Storage & Stability Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles.

Examples
  • IGF2R Domain 1-7, His & Avi, Human
    • IGF2R Domain 1-7, His & Avi, Human

    The purity of IGF2R Domain 1-7, His & Avi, Human is greater than 95% as determined by SEC-HPLC.

  • IGF2R Domain 1-7, His & Avi, Human
    • IGF2R Domain 1-7, His & Avi, Human

    IGF2R Domain 1-7, His & Avi, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.


Background
Target Background The cation-independent mannose-6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) is a multifunctional receptor. It is involved in a variety of cellular processes which become dysregulated in cancer.
Synonyms CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.